5.50Open5.90Pre Close12 Volume89 Open Interest12.50Strike Price6.69KTurnover136.06%IV0.03%PremiumDec 20, 2024Expiry Date5.60Intrinsic Value100Multiplier16DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.9244Delta0.0277Gamma3.15Leverage Ratio-0.0239Theta0.0048Rho2.91Eff Leverage0.0054Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet